• 제목/요약/키워드: Radioactive iodine

검색결과 188건 처리시간 0.021초

Preliminary study on the efficacy of xerostomia treatment with sialocentesis targeting thyroid disease patients given radioiodine therapy

  • Kim, Euy-Hyun;Lee, Dong-Keon;Kim, Chang-Woo;Song, In-Seok;Jun, Sang-Ho
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제41권
    • /
    • pp.39.1-39.6
    • /
    • 2019
  • Background: Radioiodine therapy has been widely used for thyroid disease patients, but hyposalivation and xerostomia may occur in 10~30% of patients. Sialocentesis is a procedure that removes inflammatory substances in the salivary duct and expands the duct for the secretion and delivery of saliva. In this study, thyroid disease patients treated with radioactive iodine were selected among the patients with xerostomia who visited the hospital, and the effect of sialocentesis was compared and analyzed. And then, comparison between the radioiodine therapy-experienced group and the non-radioiodine therapy-experienced group was conducted. Results: In this study, we studied xerostomia patients who underwent radioiodine therapy due to thyroid diseases and who underwent sialocentesis at the Korea University Anam Hospital. Sialocentesis is conducted by one surgeon. The study also compares the clinical symptoms before and after the surgery. After the procedure, the discomfort due to xerostomia was reduced, and the symptom was improved effectively. Conclusions: The results of this study showed that sialocentesis has a clinical effect in the treatment of xerostomia, which is a side effect of radioiodine therapy. In addition, the possibility of further clinical application of sialocentesis in the future is found.

경부 종물로 발현된 유두 미세 갑상선암 (Papillary Thyroid Microcarcinoma Presenting as Neck Masses)

  • 김영모;박선기;신준순;전용선;한창준;조정일
    • 대한두경부종양학회지
    • /
    • 제18권1호
    • /
    • pp.65-70
    • /
    • 2002
  • Background and Objectives: Recently the tenn 'papillary microcarcinoma' has been proposed to designate carcinoma of 10 mm or less in diameter. In some cases, cervical lymph node metastasis preceding the occurrence of the primary tumor may be the first and sole manifestation of the disease. The objective of this study is to assess the clinical features of cervical metastasis in papillary microcarcinoma of thyroid glands. Materials and Methods: 9 cases with papillary microcarcinoma with neck metastasis were analyzed retrospectively. 5 cases are men and 4 are women. All patients complained of painless, movable neck mass. The symptom had been present from 1 month to 36 months. We reviewed clinical history, imaging studies, the results of fine needle aspiration, the surgical method, the pathologic results. Results: In 9 cases, no abnormalities of the thyroid gland were shown by imaging studies and thyroid scan. 3 cases were diagnosed by fine needle aspiration cytology. the others were not. Total thyroidectomy and neck dissection were performed in 9 cases and then pathology reports showed 2 case of multiple, 2 case of contralateral single and 5 cases of unilateral single thyroid microcarcinoma. They have no recurrence during follow-up period. Conclusions: Cervical metastasis from papillary microcarcinoma is variable clinical manifestation. The diagnosis of cervical metastasis from papillary microcarcinoma should be considered in patient with neck mass. We recommend total thyroidectomy with neck dissection and postoperative radioactive iodine ablation therapy in neck metastasis from papillary thyroid microcarcinoma.

갑상선 기능저하 음성에 대한 청지각적 및 파열음 분석에 대한 연구 (The Perceptual and Consonant Analysis for the Voice with Hypothyroidism)

  • 한백화;이다해;김준선;홍기환
    • 대한후두음성언어의학회지
    • /
    • 제27권2호
    • /
    • pp.95-101
    • /
    • 2016
  • Background and Objectives : The main purpose of this study is to clarify perceptual and acoustic analysis for the patients with hypothyroidism after thyroidectomy especially focused on the characteristics of speech articulation with special reference to the consonant production. Materials and Methods : The subjects of the research were 40 male and female adults (males : 5, females : 35). They were all received radioactive iodine treatment which after total thyroidectomy. Voice samples were collected during the three stages of after surgery, pre-radioisotope treatment (RIT), and post-RIT. The acoustic analysis was conducted by using Pratt (ver.5.2.21) after measuring voice onset time (VOT). The subjective evaluation of the voices used CAPE-V. Results : A significant decrease in overall severity was displayed in the CAPE-V following RIT. It may be conjectured that this is connected to the change in voice following RIT. The loudness of the sound displayed a significant decrease in the CAPE-V following RIT. It is conjectured that this is connected to the decrease in vocal intensity following RIT. No statistically significant results were revealed for the comparative analysis on the voice onset time (VOT) in all plosives during the three periods. Conclusion : Perceptually, the overall severity of the voice with hypothyroidism was changed significantly before and after RIT. Eventhough VOT were not significantly changed, it tended to decrease VOT in patients with hypothyroidism.

  • PDF

Metastatic papillary thyroid cancers with malignant pleural effusion aggravated during thyroid hormone withdrawal for radioiodine therapy

  • Seo, Ji Hye;Je, Ji Hye;Lee, Hyun Jung;Na, Young Ju;Jeong, Il Woo;An, Jee Hyun;Kim, Sin Gon;Choi, Dong Seop;Kim, Nam Hoon
    • Journal of Yeungnam Medical Science
    • /
    • 제32권2호
    • /
    • pp.138-142
    • /
    • 2015
  • L-thyroxine (LT4) withdrawal prior to radioactive iodine (RAI) ablation therapy is a commonly used method for successful treatment of patients with papillary thyroid cancer (PTC). However, a prolonged period of hypothyroidism induced by LT4 withdrawal is sometimes associated with impaired quality of life and cardiopulmonary dysfunction in PTC patients. Furthermore, LT4 withdrawal may have a trophic effect on residual cancer by means of increased thyrotropin. We report on 2 cases of metastatic PTC patients with malignant pleural effusion (MPE) whose disease showed rapid worsening after LT4 withdrawal and RAI therapy. The first case is a 65-year-old woman who had PTC with multiple distant metastases and MPE. During LT4 withdrawal for RAI therapy, MPE showed rapid worsening, and the patient required repetitive therapeutic thoracentesis. The second case is a 49-year-old woman with PTC who underwent 3 additional operations for cancer recurrence in the neck lymph nodes and 6 times of RAI treatments. While preparing for the $7^{th}$ RAI treatment by withdrawing LT4, she developed MPE which became progressively aggravated after RAI therapy. Both patients experienced increased pleural effusion during the LT4 withdrawal period and a rise in the thyroglobulin level was observed after RAI therapy. MPE was not controlled with therapeutic thoracentesis and pleurodesis. Eventually, both patients died of rapid disease progression after RAI therapy. In summary, LT4 withdrawal may have an adverse effect on metastatic PTC patients, particularly those with MPE.

PWR 사용후핵연료 중 탄소-14 및 트리튬 정량 (Determination of carbon-14 and tritium in a PWR spent nuclear fuel)

  • 김정석;박순달;이창헌;송병철;지광용
    • 분석과학
    • /
    • 제18권4호
    • /
    • pp.298-308
    • /
    • 2005
  • 사용후핵연료시료 중에 함유된 탄소-l4와 트리튬을 회수 및 정량하였다. $CO_2$ 운반체($CaCO_3$)를 포함한 사용후핵연료시료를 $90^{\circ}C$에서 8M $HNO_3$ 용액으로 용해하면서 휘발된 $^{14}CO_2$를 1.5 M NaOH 용액을 포함한 포집관에 수집하였다. 용해 중 휘발되는 방사성 요오드는 Ag-silica gel 흡착체를 담은 포집 관으로 사전제거하였다. 핵연료 용해용액 중에 남아있는 트리튬(HTO)를 정량하기 위하여 양이온과 음이온 교환수지 혼합물 및 무기이온교환체를 이용한 뱃치 및 분리관법으로 용해용액을 탈이온화시켜 간섭이온을 제거하였다. 포집용액 중의 탄소-14와 탈이온화수 중의 트리튬을 액체섬광계수법으로 정량하였다.

흰쥐에서 발암물질로 유발된 갑상선 종양과 p21 및 p53 단백질의 발현 (Development of Thyroid Tumors by Carcinogens and Its Expression of p21 & p53 Protein in Rats)

  • 백종민;장석균
    • 대한두경부종양학회지
    • /
    • 제15권2호
    • /
    • pp.141-148
    • /
    • 1999
  • Objectives: The development of thyroid tumor has a relationship with carcinogen, oncogene and tumor suppressor gene. With aminotriazole, radioactive iodine and nitrosomethylurea as carcinogens in rat, authors investigate the incidence in type of the thyroid tumors, p21 and p53 protein expression pattern by immunohistochemical stain and the relationship between the tumors and p21-p53 protein expressions. Materials and Methods: 80 experimental animals were divided into four groups; group 1(control, no carcinogen, n=20), group 2(oral administration of aminotriazole for 36 weeks, n=20), group 3(intraperitoneal injection of 131I for one time and oral administration of aminotriazole for 36 weeks, n=20), group 4(oral administration of nitrosomethylurea for 3 days and aminotriazole for 36 weeks, n=20). After 40 weeks they were sacrificed with pathologic examination and we performed immunohistochemical staining with pan-ras monoclonal antibody for p21 protein and CMI polyclonal antibody for p53 protein with paraffin-embedded specimens. Results: 1) No tumors were observed in group I, but 38.3% of nodular goiters, 11.7% of adenomas and 50.0% of carcinomas were observed in carcinogen treated groups(group 2, 3, 4). 2) The incidence of nodular goiter, adenoma and carcinoma were 70%, 20% and 10% in group 2, 40%, 15% and 45% in group 3 and 5%, 0% and 95% in group 4. 3) p21 protein was not expressed in normal thyroid tissues but was expressed in 26.1% of nodular goiters, 42.9% of adenomas and 6.7% of carcinomas. On the other hands, p53 protein was not expressed in normal thyroid tissues, nodular goiters, adenomas and in well differentiated thyroid carcinomas by immunohistochemical stain. Conclusion: The authors suggest that aminotrizole, 131I, nitrosomethylurea can be etiologic agents in the development of thyroid tumor and the p21 protein can be expressed in the early stage and in benign condition of thyroid tumor but p53 protein is not expressed in all conditions of development in rats.

  • PDF

갑상선암 환자에서 방사성옥소치료 후 안전하게 이동할 수 있는 시간을 계산하기 위한 실용적인 간편계산법 제안 (Suggestion of A Practical Simple Calculation Method for Safe Transportation Time after Radioactive Iodine Treatment in Patients with Thyroid Cancer)

  • 박석건
    • 한국산학기술학회논문지
    • /
    • 제16권6호
    • /
    • pp.3919-3925
    • /
    • 2015
  • 방사성옥소 치료를 받은 환자가 격리 후 차량으로 귀가할 때 동승자가 받는 방사선 피폭량을 줄이기 위해서는 동승하는 시간을 적절하게 제한해야 한다. 계산 방법이 어렵기 때문에 현재까지 일반적인 가이드라인은 있어도 환자 개개인의 상태를 반영하는 기준은 없었다. 그런데 비교적 짧은 이동시간 동안에는 소변을 통한 배출이 없고 물리적인 붕괴도 없다는 가정을 하면 총선량 = 선량율 ${\times}$ 이동시간이라는 아주 간편한 계산을 할 수 있다. 입원했던 환자 120명의 데이터를 활용하여 이 간편계산법과 표준적인 계산법으로 계산한 결과를 비교하였다. 이동가능 시간을 계산했을 때 간편계산의 결과는 표준적인 방법에 비해 0.3 m 거리에서는 56%, 0.5 m 거리에서는 91%, 1 m 거리에서는 96%였다. 간편계산법은 안전한 방법이며, 방사선안전관리 방법으로 쉽게 적용할 수 있을 것이다. 또한 방사성옥소 치료를 받는 갑상선기능항진증 환자에서도 적용이 가능하다.

Columnar variant of papillary carcinoma in the thyroglossal duct cyst with progression to lung metastasis

  • Yun, Yujung;Park, Hye Jung;Lee, Young Ki;Cho, Yongin;Kang, Beoduel;Kim, Hyun Ju;Lee, Jung-Hee;Jin, Moo-Nyun;Shin, Dong Yeob
    • Journal of Yeungnam Medical Science
    • /
    • 제31권2호
    • /
    • pp.103-108
    • /
    • 2014
  • Thyroglossal duct cyst (TGDC) carcinoma generally shows a favorable prognosis. If metastasis is present latently, it may not threaten the patient's life immediately. It has been shown, however, that larger than 1 cm papillary carcinoma (PC), level VI metastasis to the lymph node (LN), which is the nearest to the thyroid, independently predicts a worse prognosis. In the case presented herein, a 61-year-old female patient was diagnosed with an about 3 cm PC in the TGDC, particularly the columnar variant subtype, one of the aggressive variants. She had occult papillary thyroid microcarcinoma, but no LN metastasis. Even though she underwent the Sistrunk procedure and total thyroidectomy with central compartment neck dissection followed by high-dose radioactive iodine remnant ablation, however, the cancer cells spread to level IV neck LN, and finally to the lung. Therefore, when a patient is diagnosed with an aggressive histologic variant of PC in the TGDC, even without LN metastasis, the invasive surgical approach and close postoperative surveillance are necessary, with consideration of the risk of disease progression. Therefore, if it is possible to stratify the risk for patients, higher-risk patients can be offered a more invasive therapeutic approach.

방사성 옥소 치료 후 분화된 갑상선암 추적관찰에서 Thallium-201 스캔, Tc-99m MIBI 스캔과 I-131 스캔 검사 결과의 비교 (Comparison of Thallium-201, Tc-99m MIBI and I-131 Scan in the Follow-up Assessment after I-131 Ablative Therapy in Differentiated Thyroid Cancer)

  • 권재성;이성근;김도민;박세종;장경순;김은실;김종순
    • 대한핵의학회지
    • /
    • 제33권6호
    • /
    • pp.493-501
    • /
    • 1999
  • 목적 : 분화된 갑상선암에서 암 절제술 및 방사성 옥소 치료 후 추적관찰 중 재발이나 전이병소를 찾기 위한 효과적인 검사 방법에 대한 자료를 제시하고자 T1-201 스캔, Tc-99m MIBI 스캔, I-131 스캔 검사의 결과를 비교하였다. 대상 및 방법: 분화된 갑상선암으로 진단되어 수술 및 방사성 옥소로 치료 후 추적관찰 중 국소 재발 또는 전이로 생각되어 한번이상의 방사성 옥소 재 치료를 시행한 20명(총 33예)의 환자를 대상하여 T1-201 스캔, Tc-99m MIBI 스캔, 진단적 및 치료적 I-131 스캔을 시행하여 각 스캔에서 결과를 후향적으로 분석하였다. 모든 환자에서 갑상선글로불린을 측정하였고 임상적, 방사선학적, 조직학적 검사로 암의 재발 및 전이를 확인하였다. 결과: 4가지 검사의 비교에서 병소를 발견할 수 있는 양성률은 Tc-99m MIBI 스캔, T1-201 스캔, 진단적 I-131 스캔, 치료적 I-131 스캔에서 각각 70% (19/27), 54% (15/28), 35% (17/48), 63% (30/48)였다. T1-201 스캔과 I-131 스캔을 같이 시행한 군(20 예, 28병소)에서는 병소의 양성률은 치료적 I-131 스캔, T1-201 스캔, 진단적 I-131 스캔 순으로 높았으나(71%, 54%, 36%), T1-201 스캔과 진단적 I-131 스캔간의 차이는 없었다(p>0.05). Tc-99m MIBI 스캔을 I-131 스캔과 같이 시행한 군(20예, 27병소)에 서는 Tc-99m MIBI, 치료적 I-131 스캔, 진단적 I-131 스캔의 순으로 높았고(70%, 52%, 33%), Tc-99m MIBI는 진단적 I-131 스캔보다 양성률이 유의하게 높았다(p<0.05). 결론: 분화된 갑상선암 환자의 치료 후 추적 관찰에서 국소 재발 및 전이 병소를 찾는데 Tc-99m MIBI 스캔은 진단적 I-131 스캔보다 우수하였다. 따라서 치료 전에 진단적 I-131 스캔을 시행하기보다는 갑상선 호르몬제를 중단하지 않은 상태에서 Tc-99m MIBI 스캔을 시행한 후 결과에 따라서 치료용량의 방사성 옥소를 투여하고 치료적 I-131 스캔을 하는 것이 효과적일 것으로 사료된다.

  • PDF

표준계수 측정 시 기하학적 요인이 방사성 요오드 갑상선 섭취율에 미치는 영향 (The Effect of Geometric Factors When Measuring Standard Count for Radioactive Iodine Thyroid Uptake Rate)

  • 오주영;김정열;오기백;오신현;김재삼;이창호;박훈희
    • 핵의학기술
    • /
    • 제17권1호
    • /
    • pp.53-61
    • /
    • 2013
  • 방사성 요오드 갑상선 섭취율은 거대갑상선 환자의 경우 그 체적에 의한 유효 갑상선 깊이가 깊어짐으로 인한 기하학적 변동이 있는 것이 사실이다. 본 연구는 방사성 요오드갑상선 섭취율에 있어 검출기와 선원 간 거리와 유효 갑상선 깊이에 따른 기하학적 요인의 영향을 고찰하고자 하였다. $^{131}I$ 370 kBq 선원을 검출기로부터 거리를 20 cm부터 30cm까지 1 cm 간격으로 변화시키며 Captus 3000 thyroid uptake system(Capintec, NJ, USA)으로 측정하였다. 유효갑상선 깊이를 재현하기 위해 목 팬텀을 이용하여 팬텀 내 선원의 깊이를 1 cm, 2 cm, 5 cm으로 변화시키며 같은 방법으로 측정하였다. 실험 결과, 곡선추정 회귀분석 결과 모든 실험군이 거듭제곱곡선에 높은 상관관계를 보이는 것으로 나타났다($$R2{\geq_-}0.915$$). 그러므로 검출기-선원 간 거리가 20 cm보다 30 cm에서 오차가 크게 감소됨을 예상할 수 있다. 모든 실험군에서 팬텀을 쓰지 않았을 때와 유효 갑상선깊이가 1 cm이 적용되었을 때의 계수율이 서로 유의할 만한 차이가 있는 것으로 나타났다(p<0.01). 선형회귀분석 결과 깊이에 따른 계수율의 변화는 모두 감소되는 것으로 나타났으나,$284.3keV{\pm}10%$ 영역에서 깊이에 따른 계수율의 변화는 증가되는 것으로 나타났다. 이 회귀식을 통해 환자의 예상 갑상선 섭취율을 산출해 보았을 때, $364.4keV{\pm}10%$에서 1 cm 당 -6.42%, $364.4keV{\pm}20%$의 영역에 서 -5.09%의 더 낮은 오차를 보였다. 또한 거리에 따른 계수율의 변동계수는 모든 실험군에서 선형으로 증가되는 것으로 나타났다. 그 중 $364.4keV{\pm}20%$, $364.4keV{\pm}10%$ 영역은 비교적 낮은 변동계수와 증가폭을 보였다. 곧, 유효 갑상선 깊이에 따른 오차를 줄이기 위해서는 $364.4keV{\pm}20%$의 영역의 사용이 더 적절할 것으로 보인다. 그러므로 갑상선 깊이에 따른 오차는 갑상선 깊이에 따른 보정계수 적용,$364.4keV{\pm}20%$ 에너지 영역 설정, 디텍터와 선원과의 거리를 연장하였을 때 감소시킬 수 있다고 생각된다.

  • PDF